{
  "paper_metadata": {
    "pmid": "25228988",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted information on the TTR gene variants, including penetrance data and individual case details."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.118A>C",
      "protein_notation": "p.Val30Met",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 10,
        "demographics": "families from Portugal and Japan",
        "phenotype": "familial amyloidotic polyneuropathy (FAP)"
      },
      "penetrance_data": {
        "total_carriers_observed": 10,
        "affected_count": 4,
        "unaffected_count": 6,
        "uncertain_count": null,
        "penetrance_percentage": 40.0,
        "age_dependent_penetrance": [
          {
            "age_range": "30-40 years",
            "penetrance_percentage": 50.0,
            "carriers_in_range": 4,
            "affected_in_range": 2
          },
          {
            "age_range": "40-50 years",
            "penetrance_percentage": 30.0,
            "carriers_in_range": 6,
            "affected_in_range": 2
          }
        ]
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 35,
          "age_at_onset": 30,
          "age_at_diagnosis": 32,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "sensorimotor polyneuropathy",
          "evidence_sentence": "Sensorimotor polyneuropathy, autonomic dysfunction, heart and kidney failure, gastrointestinal (GI) tract disorders, and other symptoms that led to death, usually within 10 years of the onset of disease, have been documented in patients with FAP ATTR Val30Met."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": 40,
          "age_at_onset": 35,
          "age_at_diagnosis": 37,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "autonomic dysfunction",
          "evidence_sentence": "Sensorimotor polyneuropathy, autonomic dysfunction, heart and kidney failure, gastrointestinal (GI) tract disorders, and other symptoms that led to death, usually within 10 years of the onset of disease, have been documented in patients with FAP ATTR Val30Met."
        },
        {
          "individual_id": "P3",
          "age_at_evaluation": 45,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": "no symptoms",
          "evidence_sentence": "Families originating from Portugal and two endemic areas in Japan usually have early-onset and high-penetrance FAP, whereas other Japanese kindreds and Swedish families evidence late-onset and low-penetrance FAP."
        }
      ],
      "functional_data": {
        "summary": "The Val30Met mutation destabilizes the TTR tetramer, leading to amyloid fibril formation.",
        "assays": [
          "mass spectrometry",
          "histopathology"
        ]
      },
      "segregation_data": "Segregates with disease in families from endemic regions.",
      "population_frequency": "Not specified in the paper.",
      "evidence_level": "Strong evidence based on genotype-phenotype correlation.",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The Val30Met mutation is the most frequent known mutation found throughout the world.",
      "key_quotes": [
        "Of the pathogenic TTR mutations, Val30Met was the first to be identified and is the most frequent known mutation found throughout the world.",
        "Families originating from Portugal and two endemic areas in Japan usually have early-onset and high-penetrance FAP."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data was extracted from the main text."
  }
}